Literature DB >> 30032118

Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review.

David Giannandrea1, Michele Romoli2, Carla Caponi3, Anna Mengoni4, Claudia Marando5, Antongiulio Gallina5, Erica Marsili5, Elisa Sacchini5, Sara Mastrocola5, Chiara Padiglioni5, Tatiana Mazzoli5, Silvia Cenciarelli5, Stefano Ricci5.   

Abstract

Entities:  

Keywords:  dabigatran; idarucizumab; stroke; thrombolysis; thrombolytic therapy

Year:  2018        PMID： 30032118     DOI： 10.1136/jnnp-2018-318658

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

Review 1.  Patients on NOACs in the Emergency Room.

Authors:  Stefan T Gerner; Hagen B Huttner
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-29       Impact factor: 5.081

2.  Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab.

Authors:  Chee Hoou Loh; Geoffrey Herkes
Journal:  BMJ Case Rep       Date:  2019-05-05

3.  Idarucizumab administration in emergency situations: the Munich Registry of Reversal of Pradaxa® in clinical routine (MR REPAIR).

Authors:  Clemens Küpper; Katharina Feil; Matthias Klein; Regina Feuerecker; Marc Lücking; Florian Thanbichler; Dennis Dietrich; Irene Zerkaulen; Mitja Jandl; Martin Marziniak; Holger Poppert; Silke Wunderlich; Helge Topka; Marianne Dieterich; Lars Kellert
Journal:  J Neurol       Date:  2019-08-02       Impact factor: 4.849

4.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.

Authors:  Eivind Berge; William Whiteley; Heinrich Audebert; Gian Marco De Marchis; Ana Catarina Fonseca; Chiara Padiglioni; Natalia Pérez de la Ossa; Daniel Strbian; Georgios Tsivgoulis; Guillaume Turc
Journal:  Eur Stroke J       Date:  2021-02-19

Review 5.  A review of guidelines on anticoagulation reversal across different clinical scenarios - Is there a general consensus?

Authors:  Truman J Milling; Charles V Pollack
Journal:  Am J Emerg Med       Date:  2020-05-28       Impact factor: 4.093

6.  Left atrial appendage thrombus on full-dose dabigatran treatment: a case report.

Authors:  Paolo Candelaresi; Angela Iannuzzi; Giovanna Servillo; Rossella Gottilla
Journal:  Eur Heart J Case Rep       Date:  2020-04-24

7.  Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.

Authors:  Thomas Raphael Meinel; Sebastién Frey; Marcel Arnold; Sarah Kendroud; Urs Fischer; Johannes Kaesmacher; Mirjam Rachel Heldner; Simon Jung
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

8.  Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.

Authors:  Toshiyuki Ohtani; Ryosuke Sintoku; Tasuku Yajima; Naoyuki Kaneko
Journal:  J Med Case Rep       Date:  2019-12-26

9.  Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature.

Authors:  Angelos Sharobeam; Brett Jones; Dianne Walton-Sonda; Christian J Lueck
Journal:  J Neurol       Date:  2020-03-21       Impact factor: 4.849

10.  Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature.

Authors:  Senta Frol; Dimitrios Sagris; Janja Pretnar Oblak; Mišo Šabovič; George Ntaios
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.